Personal information

Other IDs

Scopus Author ID: 57202076363

Activities

Collapse all

Employment (1)

Department of Health: Zurich, CH

2020-07-01 to 2021-02-28 | Contact Tracing Analyst
Employment
Source: Self-asserted source
Hélène Eloise Aschmann

Education and qualifications (5)

University of California, San Francisco: San Francisco, US

2023-04-01 to present (Division of Pulmonary and Critical Care Medicine)
Education
Source: Self-asserted source
Hélène Eloise Aschmann

University of Zurich: Zürich, CH

2020-05-27 to present | Postdoctoral researcher (EBPI)
Education
Source: Self-asserted source
Hélène Eloise Aschmann

University of California, San Francisco: San Francisco, California, US

2021-04-01 to 2023-03-31 | Postdoctoral researcher (Department of Epidemiology and Biostatistics)
Education
Source: Self-asserted source
Hélène Eloise Aschmann

University of Zurich: Zurich, Zürich, CH

2016-04-01 to 2020-05-26 | PhD candidate in Epidemiology (Epidemiology, Biostatistics and Prevention Institute)
Education
Source: Self-asserted source
Hélène Eloise Aschmann

Swiss Federal Institute of Technology in Zurich: Zurich, Zürich, CH

2013-09 to 2015-04 | Master in Medicinal and Industrial Pharmaceutical Sciences (Pharmaceutical Sciences)
Education
Source: Self-asserted source
Hélène Eloise Aschmann

Works (39)

Predicted choice and acceptability of regimens for tuberculosis preventive treatment among people living with HIV in Uganda – a discrete choice experiment

2025-03-13 | Preprint
DOI: 10.1101/2025.03.12.25323350
Contributors: Hélène E. Aschmann; Allan Musinguzi; Jillian L. Kadota; Catherine Namale; Juliet Kakeeto; Jane Nakimuli; Lydia Akello; Fred Welishe; Anne Nakitende; Christopher Berger et al.
Source: check_circle
Crossref

Preferences of people living with HIV for features of tuberculosis preventive treatment regimens in Uganda: a discrete choice experiment

Journal of the International AIDS Society
2024-12 | Journal article
DOI: 10.1002/jia2.26390
Contributors: Hélène E. Aschmann; Allan Musinguzi; Jillian L. Kadota; Catherine Namale; Juliet Kakeeto; Jane Nakimuli; Lydia Akello; Fred Welishe; Anne Nakitende; Christopher Berger et al.
Source: check_circle
Crossref

Adverse Events Reported During Weekly Isoniazid-Rifapentine (3HP) Tuberculosis Preventive Treatment Among People With Human Immunodeficiency Virus in Uganda

Open Forum Infectious Diseases
2024-10-30 | Journal article
DOI: 10.1093/ofid/ofae667
Contributors: Jillian L Kadota; Allan Musinguzi; Hélène E Aschmann; Lydia Akello; Fred Welishe; Jane Nakimuli; Christopher A Berger; Noah Kiwanuka; Patrick P J Phillips; Achilles Katamba et al.
Source: check_circle
Crossref

Preferences of people living with HIV for features of tuberculosis preventive treatment regimens – a discrete choice experiment

2023-09-14 | Preprint
DOI: 10.1101/2023.09.13.23295043
Contributors: Hélène E. Aschmann; Allan Musinguzi; Jillian L. Kadota; Catherine Namale; Juliet Kakeeto; Jane Nakimuli; Lydia Akello; Fred Welishe; Anne Nakitende; Christopher Berger et al.
Source: check_circle
Crossref

SARS-CoV-2 quarantine mandated by contact tracing: burden and infection rate among close contacts in Zurich, Switzerland, 2020-2021

2023-09-05 | Preprint
DOI: 10.1101/2023.09.03.23294798
Contributors: Hélène E. Aschmann; Anja Domenghino; Ruedi Jung; Tala Ballouz; Dominik Menges; Jan Fehr; Milo A. Puhan
Source: check_circle
Crossref

Excess Mortality With Alzheimer Disease and Related Dementias as an Underlying or Contributing Cause During the COVID-19 Pandemic in the US

JAMA Neurology
2023-07-17 | Journal article
DOI: 10.1001/jamaneurol.2023.2226
Part of ISSN: 2168-6149
Contributors: Ruijia Chen; Marie-Laure Charpignon; Rafeya V. Raquib; Jingxuan Wang; Erika Meza; Hélène E. Aschmann; Michelle A. DeVost; Alyssa Mooney; Kirsten Bibbins-Domingo; Alicia R. Riley et al.
Source: Self-asserted source
Hélène Eloise Aschmann

Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study

BMJ
2023-05-31 | Journal article
DOI: 10.1136/bmj-2022-074425
DOI: 10.1101/2022.06.22.22276746
Part of ISSN: 1756-1833
Contributors: Tala Ballouz; Dominik Menges; Alexia Anagnostopoulos; Anja Domenghino; Hélène E Aschmann; Anja Frei; Jan S Fehr; Milo Puhan
Source: Self-asserted source
Hélène Eloise Aschmann
grade
Preferred source (of 2)‎

Best-worst scaling preferences among patients with well-controlled epilepsy: Pilot results

PLOS ONE
2023-03-03 | Journal article
DOI: 10.1371/journal.pone.0282658
Part of ISSN: 1932-6203
Contributors: Samuel Terman; Hélène E. Aschmann; David W. Hutton; James F. Burke
Source: Self-asserted source
Hélène Eloise Aschmann

Association between willingness to deprescribe and health outcome priorities among U.S. older adults: Results of a national survey

Journal of the American Geriatrics Society
2022-10 | Journal article
DOI: 10.1111/jgs.17917
Part of ISSN: 0002-8614
Part of ISSN: 1532-5415
Contributors: Ariel Green; Hélène Eloise Aschmann; Cynthia M. Boyd; Nancy Schoenborn
Source: Self-asserted source
Hélène Eloise Aschmann

Dynamics of racial disparities in all-cause mortality during the COVID-19 pandemic

Proceedings of the National Academy of Sciences
2022-10-04 | Journal article
DOI: 10.1073/pnas.2210941119
Contributors: Hélène E. Aschmann; Alicia R. Riley; Ruijia Chen; Yea-Hung Chen; Kirsten Bibbins-Domingo; Andrew C. Stokes; M. Maria Glymour; Mathew V. Kiang
Source: check_circle
Crossref

COVID-19 mortality and excess mortality among working-age residents in California, USA, by occupational sector: a longitudinal cohort analysis of mortality surveillance data

The Lancet Public Health
2022-09 | Journal article
DOI: 10.1016/s2468-2667(22)00191-8
Part of ISSN: 2468-2667
Contributors: Yea-Hung Chen; Alicia R Riley; Kate A Duchowny; Hélène Eloise Aschmann; Ruijia Chen; Mathew V Kiang; Alyssa C Mooney; Andrew C Stokes; M Maria Glymour; Kirsten Bibbins-Domingo
Source: Self-asserted source
Hélène Eloise Aschmann

Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort

Nature Communications
2022-08-18 | Journal article
DOI: 10.1038/s41467-022-32573-w
DOI: 10.1101/2021.12.15.21267776
Part of ISSN: 2041-1723
Contributors: Hélène Eloise Aschmann
Source: Self-asserted source
Hélène Eloise Aschmann
grade
Preferred source (of 2)‎

Fingolimod versus interferon beta 1-a: Benefit–harm assessment approach based on TRANSFORMS individual patient data

Multiple Sclerosis Journal - Experimental, Translational and Clinical
2022-07 | Journal article
DOI: 10.1177/20552173221117784
Contributors: Alessandra Spanu; Hélène E Aschmann; Jürg Kesselring; Milo A Puhan
Source: check_circle
Crossref

Excess natural-cause deaths in California by cause and setting: March 2020 through February 2021

PNAS Nexus
2022-07-01 | Journal article
DOI: 10.1093/pnasnexus/pgac079
Contributors: Yea-Hung Chen; Andrew C Stokes; Hélène E Aschmann; Ruijia Chen; Shelley DeVost; Mathew V Kiang; Suneil Koliwad; Alicia R Riley; M Maria Glymour; Kirsten Bibbins-Domingo et al.
Source: check_circle
Crossref

Racial and Ethnic Disparities in Estimated Excess Mortality From External Causes in the US, March to December 2020

JAMA Internal Medicine
2022-07-01 | Journal article
DOI: 10.1001/jamainternmed.2022.1461
Part of ISSN: 2168-6106
Contributors: Ruijia Chen; Hélène Eloise Aschmann; Yea-Hung Chen; M. Maria Glymour; Kirsten Bibbins-Domingo; Andrew C. Stokes; Mathew V. Kiang
Source: Self-asserted source
Hélène Eloise Aschmann

Individual-Level Evaluation of the Exposure Notification Cascade in the SwissCovid Digital Proximity Tracing App: Observational Study

JMIR Public Health and Surveillance
2022-05-19 | Journal article
DOI: 10.2196/35653
Contributors: Tala Ballouz; Dominik Menges; Hélène E Aschmann; Ruedi Jung; Anja Domenghino; Jan S Fehr; Milo A Puhan; Viktor von Wyl
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Large-scale prevention trials could provide stronger evidence for decision-makers: Opportunities to design and report with a focus on the benefit–harm balance

Clinical Trials
2022-04 | Journal article
DOI: 10.1177/17407745211068549
Contributors: Hélène E Aschmann; John J McNeil; Milo A Puhan
Source: check_circle
Crossref

Rejoinder to Dr Vickers

Clinical Trials
2022-04 | Journal article
DOI: 10.1177/17407745211068548
Contributors: Hélène E Aschmann; John J McNeil; Milo A Puhan
Source: check_circle
Crossref

Mental health of individuals infected with SARS-CoV-2 during mandated isolation and compliance with recommendations—A population-based cohort study

PLOS ONE
2022-03-16 | Journal article
DOI: 10.1371/journal.pone.0264655
Part of ISSN: 1932-6203
Contributors: Anja Domenghino; Hélène Eloise Aschmann; Tala Ballouz; Dominik Menges; Dominique Strebel; Sandra Derfler; Jan S. Fehr; Milo Puhan
Source: Self-asserted source
Hélène Eloise Aschmann

Adherence and Association of Digital Proximity Tracing App Notifications With Earlier Time to Quarantine: Results From the Zurich SARS-CoV-2 Cohort Study

International Journal of Public Health
2021-08-16 | Journal article
DOI: 10.3389/ijph.2021.1603992
Part of ISSN: 1661-8564
Contributors: Tala Ballouz; Dominik Menges; Hélène Eloise Aschmann; Anja Domenghino; Jan S. Fehr; Milo A. Puhan; Viktor von Wyl
Source: Self-asserted source
Hélène Eloise Aschmann

Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study

PLOS ONE
2021-07-12 | Journal article
DOI: 10.1371/journal.pone.0254523
Contributors: Dominik Menges; Martin Chtolongo Simuunza; Tala Ballouz; Alexia Anagnostopoulos; Hélène E. Aschmann; Anja Domenghino; Jan S. Fehr; Milo A. Puhan
Source: check_circle
Crossref

A Data-Driven Simulation of the Exposure Notification Cascade for Digital Contact Tracing of SARS-CoV-2 in Zurich, Switzerland.

JAMA network open
2021-04-01 | Journal article
DOI: 10.1001/jamanetworkopen.2021.8184
PMID: 33929521
Source: Self-asserted source
Hélène Eloise Aschmann
grade
Preferred source (of 2)‎

Assessment of Patient-Preferred Language to Achieve Goal-Aligned Deprescribing in Older Adults.

JAMA network open
2021-04-01 | Journal article
DOI: 10.1001/jamanetworkopen.2021.2633
PMID: 33818621
PMC: PMC8022217
Contributors: Ariel R. Green; Hélène Eloise Aschmann; Cynthia M. Boyd; Nancy Schoenborn
Source: Self-asserted source
Hélène Eloise Aschmann

Burden of Post-COVID-19 Syndrome and Implications for Healthcare Service Planning: A Population-based Cohort Study

2021-03-01 | Other
DOI: 10.1101/2021.02.27.21252572
Contributors: Dominik Menges; Tala Ballouz; Alexia Anagnostopoulos; Hélène E Aschmann; Anja Domenghino; Jan S Fehr; Milo A Puhan
Source: check_circle
Crossref

[Cancer Screening - Prerequisites for a Successful and Meaningful Screening Program].

Therapeutische Umschau. Revue therapeutique
2021-02-22 | Journal article
DOI: 10.1024/0040-5930/a001239
PMID: 33615862
Contributors: Hélène Eloise Aschmann; Milo Alan Puhan
Source: Self-asserted source
Hélène Eloise Aschmann
grade
Preferred source (of 2)‎

Defining Core Competencies for Epidemiologists in Academic Settings to Tackle Tomorrow’s Health Research Challenges: A Structured, Multinational Effort

American Journal of Epidemiology
2021-02-01 | Journal article
DOI: 10.1093/aje/kwaa209
Part of ISSN: 0002-9262
Part of ISSN: 1476-6256
Contributors: Alison Abraham; Doreen Gille; Milo A Puhan; Gerben ter Riet; Viktor von Wyl; for the International Consortium on Teaching Epidemiology
Source: Self-asserted source
Hélène Eloise Aschmann

Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study

BMC Cardiovascular Disorders
2020-12 | Journal article
DOI: 10.1186/s12872-020-01697-6
Part of ISSN: 1471-2261
Contributors: Henock G Yebyo; Sofia Zappacosta; Hélène Eloise Aschmann; Sarah R. Haile; Milo A. Puhan
Source: Self-asserted source
Hélène Eloise Aschmann

Benefit-harm balance of fingolimod in patients with MS: A modelling study based on FREEDOMS

Multiple Sclerosis and Related Disorders
2020-11 | Journal article
DOI: 10.1016/j.msard.2020.102464
Part of ISSN: 2211-0348
Contributors: Alessandra Spanu; Hélène Eloise Aschmann; Jürg Kesselring; Milo A. Puhan
Source: Self-asserted source
Hélène Eloise Aschmann

Outcome preferences of older people with multiple chronic conditions and hypertension: a cross-sectional survey using best-worst scaling

Health and Quality of Life Outcomes
2019 | Journal article
DOI: 10.1186/s12955-019-1250-6
Part of ISSN: 1477-7525
Contributors: Hélène E. Aschmann; Milo A. Puhan; Craig W. Robbins; Elizabeth A. Bayliss; Wiley V. Chan; Richard A. Mularski; Renée F. Wilson; Wendy L. Bennett; Orla C. Sheehan; Tsung Yu et al.
Source: Self-asserted source
Hélène Eloise Aschmann via Crossref Metadata Search

A benefit–harm analysis of adding basal insulin vs. sulfonylurea to metformin to manage type II diabetes mellitus in people with multiple chronic conditions

Journal of Clinical Epidemiology
2019-09 | Journal article
DOI: 10.1016/j.jclinepi.2019.03.014
Part of ISSN: 0895-4356
Contributors: Wendy L. Bennett; Hélène E. Aschmann; Milo A. Puhan; Craig W. Robbins; Elizabeth A. Bayliss; Renee Wilson; Richard A. Mularski; Wiley V. Chan; Bruce Leff; Orla Sheehan et al.
Source: Self-asserted source
Hélène Eloise Aschmann via Crossref Metadata Search

Net benefit of statins for primary prevention of cardiovascular disease in people 75 years or older: a benefit–harm balance modeling study

Therapeutic Advances in Chronic Disease
2019-09 | Journal article
DOI: 10.1177/2040622319877745
Part of ISSN: 2040-6223
Contributors: Henock G. Yebyo; Hélène E. Aschmann; Dominik Menges; Cynthia M. Boyd; Milo A. Puhan
Source: Self-asserted source
Hélène Eloise Aschmann via Crossref Metadata Search

Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessment

BMJ Open
2019-08 | Journal article
DOI: 10.1136/bmjopen-2018-028438
Part of ISSN: 2044-6055
Contributors: Hélène E Aschmann; Cynthia M Boyd; Craig W Robbins; Richard A Mularski; Wiley V Chan; Orla C Sheehan; Renée F Wilson; Wendy L Bennett; Elizabeth A Bayliss; Tsung Yu et al.
Source: Self-asserted source
Hélène Eloise Aschmann via Crossref Metadata Search
grade
Preferred source (of 2)‎

Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants

American Heart Journal
2019-04 | Journal article
DOI: 10.1016/j.ahj.2018.12.007
Part of ISSN: 0002-8703
Contributors: Henock G Yebyo; Hélène E Aschmann; Marco Kaufmann; Milo A Puhan
Source: Self-asserted source
Hélène Eloise Aschmann via Crossref Metadata Search

Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease

Annals of Internal Medicine
2018 | Journal article
DOI: 10.7326/m18-1279
Part of ISSN: 0003-4819
Contributors: Henock G. Yebyo; Hélène E. Aschmann; Milo A. Puhan
Source: Self-asserted source
Hélène Eloise Aschmann via Crossref Metadata Search

Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts

BMC Cardiovascular Disorders
2018-05 | Journal article
DOI: 10.1186/s12872-018-0838-9
Part of ISSN: 1471-2261
Contributors: Henock G. Yebyo; Hélène E. Aschmann; Tsung Yu; Milo A. Puhan
Source: Self-asserted source
Hélène Eloise Aschmann via Crossref Metadata Search

Kinetics of lipid bilayer permeation of a series of ionisable drugs and their correlation with human transporter-independent intestinal permeability

European Journal of Pharmaceutical Sciences
2017-06 | Journal article
DOI: 10.1016/j.ejps.2017.03.040
Part of ISSN: 0928-0987
Contributors: Katharina F. Hermann; Claudia S. Neuhaus; Virgine Micallef; Björn Wagner; Maja Hatibovic; Hélène E. Aschmann; Franziska Paech; Rubén Alvarez-Sanchez; Stefanie D. Krämer; Sara Belli
Source: Self-asserted source
Hélène Eloise Aschmann via Crossref Metadata Search

A Comparative Analysis of Drug-Induced Hepatotoxicity in Clinically Relevant Situations

PLOS Computational Biology
2017-02-02 | Journal article
DOI: 10.1371/journal.pcbi.1005280
Part of ISSN: 1553-7358
Contributors: Christoph Thiel; Henrik Cordes; Lorenzo Fabbri; Hélène Eloise Aschmann; Vanessa Baier; Ines Smit; Francis Atkinson; Lars Mathias Blank; Lars Kuepfer; Donna K. Slonim
Source: Self-asserted source
Hélène Eloise Aschmann via Crossref Metadata Search

A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy

Antimicrobial Agents and Chemotherapy
2016-08-01 | Journal article
DOI: 10.1128/aac.00508-16
Part of ISSN: 0066-4804
Contributors: Henrik Cordes; Christoph Thiel; Hélène E. Aschmann; Vanessa Baier; Lars M. Blank; Lars Kuepfer
Source: Self-asserted source
Hélène Eloise Aschmann via Crossref Metadata Search

When barriers ignore the “rule-of-five”

Advanced Drug Delivery Reviews
2016-06 | Journal article
DOI: 10.1016/j.addr.2016.02.001
Part of ISSN: 0169-409X
Contributors: Stefanie D. Krämer; Hélène E. Aschmann; Maja Hatibovic; Katharina F. Hermann; Claudia S. Neuhaus; Cyrill Brunner; Sara Belli
Source: Self-asserted source
Hélène Eloise Aschmann via Crossref Metadata Search
How many people are using ORCID?